Growth Hormone-Releasing Hormone Analog for Secretagogue Research

General Overview:

CJC-1295 (without DAC), also known as Modified GRF 1-29, is a synthetic peptide that mimics growth hormone-releasing hormone (GHRH). Researchers study it for its ability to stimulate the body’s natural production of growth hormone in a more pulsatile, short-acting manner.

In experimental settings, scientists explore its effects on growth hormone release, recovery, and related metabolic processes, with interest in how it may support hormone balance and body composition research.

Technical Overview

CJC-1295 without DAC (also referenced as Modified GRF 1-29) is a synthetic 29-amino acid peptide analog of growth hormone-releasing hormone (GHRH). In laboratory research environments, this compound is studied for its interaction with GHRH receptors and pulsatile secretagogue signaling pathways. The tetrasubstituted modifications at positions 2, 8, 15, and 27 are examined for their role in enzymatic degradation resistance relative to endogenous GRF 1-29. The compound is synthesized using solid-phase peptide synthesis and purified by HPLC.

Strength: 10 mg lyophilized vial

For research use only. Not for human or veterinary use.